1

TCE EXPERTS BIOSKETCHES

Dr. Raymond Bruce Runyan is Professor of Cellular and Molecular Medicine atthe University of Arizona. He earned his B.A. degree from Macalest er College, St. Paul, Minnesota (Biology); his M.S. degree from Florida State University, Tall ahassee, Florida (Biology /Genetics); and his Ph.D. degree from Texas Tech University Health Scie nces Center, Lubbock, Texas (Cell Biology and Biochemistry). Dr. Runyan served as an assistan t professor at the University of Iowa’s Department of Anatomy from 1986 to 1992, when he wa s appointed to the department as associate professor with tenure. In 1992, he served on the University of Arizona’s Department of Anatomy as associate professor, until he was appoin ted associate professor with tenure in 1994 in the University of Arizona’s Department of Cell B iology and Anatomy and professor of Cellular and Molecular Medicine in 2000 (the depart ment changed its name in 2011). His research interests include the effects of TCE expos ure on valve-forming endothelial cells and on contraction in heart muscle cells. Since 1992, Dr. Runyan also has served as a scientist for the University of Arizona’s Saver Heart Center, and sin ce 1993 as member of the university’s Physiological Sciences Graduate Program. In additio n, since 2000 he has been a member of the

Steele Memorial Children’s Center and Arizona Cance r Center. He has served as an ad hoc reviewer for the National Science Foundation, Natio nal Institutes of Health (NIH), National Cancer Institute, and National Heart, Lung, and Blo od Institute, as well as serving on the American Heart Association’s Brain, Lung, and Devel opment Research Study Committee (1989- 1992) and Great Plains Review Committee (1999). He was a member of the Human Embryology and Development 2 (1994-1997) and Cardiac Different iation and Development (2006-2010) study sections for NIH. Dr. Runyan has served on nu merous national, university, collegiate and departmental committees, including The Epithelial-M esenchymal Transition International Association (TEMTIA), where he was director and sec retary (2006-2007), vice president (2007- 2008), and president (2008-2009) and has served on the Executive Board since 2010. He has served on four journal editorial boards and been a reviewer for 31 journals. He has published 57 refereed publications, authored 17 books or chapter s of books, and made dozens of invited speeches and presentations at national and internat ional conferences.

Dr. Deborah Keil is Associate Professor with the Department of Micr obiology, Medical Laboratory Sciences, at Montana State University in Bozeman. She received her B.S. degree in Clinical Laboratory Science from Western Carolina U niversity, North Carolina, and her Ph.D. degree in Biology (Immunotoxicology) from Mississip pi State University. Dr. Keil served as assistant professor in the Medical University of So uth Carolina (MUSC) Department of Medical Laboratory Sciences (1999-2002) before being promot ed to associate professor (2000-2002). After a position as a research toxicologist in the Agriculture and Immunotoxicology Group, Office of the Director, and Analytical Science Bran ch, Health Effects Laboratory Division at the National Institute for Occupational Safety and Heal th (NIOSH), Centers for Disease Control and Prevention (2002-2004), Dr. Keil held an appointmen t as associate professor, Clinical Laboratory Science Program, School of Allied Health , University of Nevada, Las Vegas (2005- 2010), and was professor (lecturer track) at the Un iversity of Utah, School of Medicine, Medical Laboratory Sciences, Department of Pathology (2010- 2012). Since 2007, she has been the medical laboratory director of the Southern Nevada Adult Mental Health Services (SNAMHS) Rawson-Neal Psychiatric Hospital in Las Vegas, Neva da, and in 2012 was appointed to the Board of Directors, American Board of Toxicology (A BT) where she is chair of the2

Globalization Committee and serves on several other ABT committees. Dr. Keil served as a review panel member for the EPA Science Advisory Bo ard Trichloroethylene Health

Assessment review in 2010. She served as the secret ary/treasurer for the Society of Toxicology’s (SOT) Women in Toxicology special interest group an d on several SOT immunotoxicology specialty sections. The focal point of her research is the immunotoxicological effects of a variety of environmental and occupational chemicals, includ ing trichloroethylene, perfluorinated compounds, jet-fuel and DEET. Dr. Keil has publishe d nine book chapters and more than 30 peer- reviewed articles, as well as some 70 proceed ings/abstracts and presentations.

Dr. Kathleen M. Gilbert is Professor with the Department of Microbiology a nd Immunology at the University of Arkansas for Medical Sciences (UA MS). She received her B.S. degree in Biology from Occidental College in Los Angeles, Cal ifornia, and her Ph.D. degree in Immunology from Tulane University, New Orleans, Lou isiana. At the Sloan-Kettering Institute, New York, New York, Dr. Gilbert was a postdoctoral research associate (1980 -1982) and a research associate (1982-1985), followed by an appo intment as a Visiting Worker at the National Institute for Medical Research, London, United King dom (1985-1987) and positions with the Department of Immunology, The Scripps Research Inst itute, La Jolla, California, as senior research associate (1987-1991) and assistant member (assistant professor) (1991-1994) before joining UAMS in 1994. She holds secondary appointme nts at the UAMS Department of Pediatrics (2002) and Department of Pharmacology an d Toxicology (2010). Among other projects, Dr. Gilbert’s laboratory is studying how different environmental toxicants including trichloroethylene (TCE) found in the water supply p romote autoimmune disease. This study uses MRL+/+ mice and examines the various immune system changes and tissue pathology that occur when these mice are exposed to environmental concen trations of TCE alone or in the presence of other toxicants. Mechanistic studies concerning how these chemicals promote T cell activation via epigenetic modifications also are under way. Th is involves examining how the developing immune system in children is especially susceptible to toxicant exposure that may lead to laterlife disease. Dr. Gilbert has published 56 peer-reviewed journal articles, 10 book chapters, in addition to 50 abstracts/posters and platform prese ntations, and more than 25 invited presentations. Dr. Gilbert was a Postdoctoral Fello w with the U.S. Public Health Service (1980- 1983) and for 25+ years has received extramural res earch funding from EPA, National Science Foundation, National Arthritis Foundation, Arthriti s Foundation, Arkansas Chapter American Cancer Society, the National Institute of Environme ntal Health Sciences and other funding organizations. She currently is editing a book on t he human health effects of TCE.

Dr. Timur S. Durrani is a Clinical Instructor of Medicine at the Univer sity of California, San Francisco (UCSF), where he holds dual appointments in the Department of Medicine, Division of Clinical Pharmacology and Experimental Therapeut ics and Department of Family Medicine. Dr. Durrani earned his Medical Degree from the Univ ersity of Arizona, where he also earned his M.P.H degree. He holds dual board certifications in Family Medicine and Preventive Medicine, and is a recent graduate of the UCSF Occupational a nd Environmental Medicine Residency and the UCSF Medical Toxicology Fellowship. His academi c responsibilities include teaching medical and pharmacy students as well as graduate m edical trainees, including Emergency Medicine and Occupational and Environmental Medicin e residents and Medical Toxicology Fellows. He provides clinical care for acutely pois oned patients at the San Francisco General Hospital, where he is a consultant for the Medical Toxicology Service, as well as outpatient3

Medical Toxicology consultations through the UCSF O ccupational and Environmental Medicine Faculty Practice. He serves as Medical Toxicology c onsultant for the Agency for Toxic Substances and Disease Registry, Region 9 and the E PA, Region 9. Dr. Durrani has publications in basic science and public health disciplines, and has presented abstracts in neurotoxicology.

Dr. James Robert Cerhan is Professor of Epidemiology at the Mayo Clinic Co llege of Medicine in Rochester, Minnesota, where he chairs t he Department of Health Sciences Research and is a consultant to the Division of Epidemiology . He also is an adjunct professor at the Department of Epidemiology, College of Public Healt h, The University of Iowa, Iowa City. Dr. Cerhan received his B.A. in Anthropology from T he University of Iowa and his Ph.D. in Epidemiology from The University of Iowa, Graduate College, followed by a Postdoctoral Fellowship in Cancer Epidemiology with the Universi ty of Minnesota, School of Public Health and an M.D. from The University of Iowa, College of Medicine. His areas of expertise are cancer etiology, prevention, and control for non-Hodgkin l ymphoma, chronic lymphocytic leukemia, prostate, and breast cancer, as well as molecular a nd genetic epidemiology. He has served on several external advisory boards, including the Min nesota Department of Public Health, Cancer Surveillance System Advisory Group (2008-Present), the University of Southern California Program Project Grant: Iatrogenic Causes of Cancer (2003-2008), and the Genentech, South San Francisco, California, National LymphoCare Study (2 004-Present). In addition, he has been an invited participant in numerous meetings, including the National Institute for Environmental Health Sciences Environmental Epidemiology in the T wenty-First Century Workshop (1999),

the National Cancer Institute Consortium on Familia l CLL (2000), the International Agency for Cancer Research NATO Advanced Research Workshop: S econd Meeting Regarding the InterLymph Collaborative Project—Perspectives of Ep idemiologic Research on Non-Hodgkin’s Lymphomas (2002), and the RAND Corporation Anaplast ic Large Cell Lymphoma (ALCL) & Breast Implants Expert Panel Meeting (2010). He has made more than 100 presentations at national and international meetings and published m ore than 300 articles, including a paper on occupational exposure to trichloroethylene and non- Hodgkin lymphoma. He has been a reviewer for many scientific journals, including Lancet, New England Journal of Medicine, JAMA, and the American Journal of Epidemiology and has served on several editorial boards, including current positions on the International Journal of Molecular Epidemiology & G enetics and Cancer

Research.

Dr. Ronald L. Melnick is a private consultant, Ron Melnick Consulting, L LC. He received his B.S. degree in Food Science from Rutgers University , New Brunswick, New Jersey, and his M.S. and Ph.D. degrees in Food Science/Biochemistryfrom the University of Massachusetts, Amherst. He was a postdoctoral research fellow in t he Department of Physiology-Anatomy at the University of California in Berkeley and then an as sistant professor of Life Sciences at the Polytechnic Institute of New York. Dr. Melnick serv ed as a toxicologist for 28+ years at the

National Institute of Environmental Health Sciences ’ (NIEHS) National Toxicology Program (NTP) for the toxicology/carcinogenesis studies on 1,3-butadiene, water disinfection byproducts, chloroprene and other chemicals as well as the NIEH S Division of Biometry and Risk Assessment and NIEHS Environmental Carcinogenesis P rogram. He was the manager of the NIEHS Experimental Toxicology Unit, Carcinogenesis and Toxicology Evaluation Branch, and group leader of the NIEHS Toxicokinetics and Bioche mical Modeling Group, Laboratory of Computational Biology and Risk Analysis, Environmen tal Toxicology Program. He spent 1 year4

as an agency representative to the White House Offi ce of Science and Technology Policy to work on interagency assessments of health risks of environmental agents and on risk assessment research needs in the federal government. He served on more than 40 advisory boards. He also was a member of EPA’s Science Advisory Board to rev iew the document “Trichloroethylene Health Risk Assessment: Synthesis and Characterizat ion” (2002); a working group member (chair of the section on cancer studies in experime ntal animals) of the International Agency for Research on Cancer for the preparation of volume 10 6 of the IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Trichlo roethylene and other chlorinated agents (2012); a reviewer of the National Research Council ’s (NRC) report, “Review of EPA’s Draft IRIS Assessment on Tetrachloroethylene,” written bythe NRC’s Board on Environmental Studies and Toxicology; and a member of the Integra ted Risk Information System (IRIS) external peer review panel of EPA’s “Toxicological Review of Trichloroacetic Acid.” He has

been a reviewer for Environmental Health Perspectives —on whose editorial board he served (1991-1997), Cancer Research, Carcinogenesis, Critical Reviews i n Toxicology, Fundamental and Applied Toxicology/Toxicological Sciences, Jour nal of the National Cancer Institute and other journals. Dr. Melnick has published 15 book c hapters, 18 technical reports, 127 journal articles, delivered 43 invited lectures, and is the recipient of the American Public Health

Association’s 2007 David P. Rall Award for science- based advocacy in public health.

Dr. Kenneth M. Portier is Managing Director of the Statistics & Evaluatio n Center at the American Cancer Society (ACS) Corporate Center in A tlanta, Georgia, Affiliate Professor of Biostatistics in the School of Public Health, EmoryUniversity, and Courtesy Professor in the Center for Environmental and Human Toxicology at th e University of Florida. Dr. Portier has a B.S. degree in mathematics (1973) from Nicholls Sta te University in Thibodaux, Louisiana, as well as an M.S. degree in Statistics (1975) and a P h.D. degree in Biostatistics (1979) from the University of North Carolina, Chapel Hill. With ACS since early 2006, Dr. Portier provides general statistical support on design and analysis of cross-sectional and longitudinal sample surveys and evaluations of ACS support programs. Pr ior to ACS, he spent 27 years as a statistical consultant to researchers in agricultur e, natural resources and the environment and as a teacher of applied statistics at the University of Florida. Dr. Portier has co-authored more than 170 publications in many of the premier journals in agriculture, natural resources and

environmental sciences. He served on EPA’s Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Science Advisory Panel (FIFRA-SAP) from2004 to 2012, the U.S. National Toxicology Program (NTP) Board of Scientific Counse lors (2007-2009) and a number of other EPA, NTP, National Institutes of Health (NIH), and World Health Organization/Food and Agriculture Organization expert panels, most recent ly the NIH Breast Cancer and Environmental Research Coordinating Committee. His present resear ch focus is on multivariate text mining techniques applied to the analysis of online cancer forum posts.

Dr. Calvin Willhite is a Contract Toxicologist with Risk Sciences Inte rnational and McLaughlin Centre for Population Health Risk Assessment (Ottaw a, Ontario, Canada). He received his B.S. degree in Zoology and his M.S. degree in Toxicologyfrom Utah State University, where he also held positions as adjunct assistant and adjunct ass ociate professor of Toxicology. He received his Ph.D. degree in Pharmacology from Dartmouth Medical School. He also was a Postdoctoral Fellow at the University of Arizona, College of Med icine, Department of Pharmacology, conducting research on inhalation toxicology and de velopmental toxicology. From 1985 to 2011,5

he was the staff toxicologist for the State of Cali fornia, involved in hazardous waste site human health risk assessments, developing and publishing chemical-specific human health risk assessments, and serving as reproduction and develo pmental toxicity research contract manager. Dr. Willhite has published more than 100 articles i n basic and applied toxicology research funded by the National Institutes of Health (NIH), U.S. Department of Agriculture, March of Dimes, the International Life Sciences Institute, N ational Science Foundation, the International Agency for Research on Cancer, the State of Califor nia and Hoffmann-La Roche. The constituents of his research range from chemicals i n occupational, submarine and ambient air; drugs in dermatology; endocrine-active drugs and en vironmental chemicals; inorganic elements and dietary supplements to regulated hazardous wast e sites. He managed $2.2 million for the

State of California human health risk assessments f or drinking water contaminants in support of Maximum Contaminant Level promulgation. He has been a member of several EPA advisory committees, including the National Advisory Committ ee for Acute Exposure Guideline Levels (2006-2009); the Trichloroethylene Issues Group, U. S. Air Force and EPA (1993); the Integrated Risk Information System (IRIS) Hexachlorobutadiene Peer Review Panel and the Peer Review Study Section, “Reducing Uncertainty in Risk Assess ment and Improving Risk Reduction Approaches” (1995). In addition, he has served on a dvisory committees for the National Academy of Sciences (NAS), including the NAS Commit tee on Toxicology (2001-2004),

National Institute of Environmental Health Sciences (NIEHS)/National Toxicology Program Scientific Advisory Committee on Alternative Toxico logical Methods (2003-2006), and NIH.

Dr. Jeffrey Driveris a Principal at risksciences.net, LLC, a consult ing firm that conducts risk analyses for consumer products, occupational, publi c, and environmental scenarios involving chemical, biological or physical agents. He obtaine d his B.S. degree in Biology and Chemistry (1983) from Bridgewater College, Virginia, and his M.P.H. (1986) and Dr.P.H. degrees (1988) in Biohazard Science (Parasitology and Laboratory Prac tice, and Environmental Sciences and Engineering Programs) from the University of North Carolina at Chapel Hill, School of Public Health. Dr. Driver is a Diplomat of the American Bo ard of Toxicology and is a licensed Medical Technologist (American Society of Clinical Patholog ists) and Clinical Laboratory Scientist (National Certification Agency). He is an adjunct f aculty member at George Mason University, and has been an Adjunct Associate Professor of Medi cine in the Division of Occupational and Environmental Medicine, Department of Medicine, Geo rge Washington University Medical

Center. He has served as a counselor for the Intern ational Society of Regulatory Pharmacology and Toxicology. Dr. Driver was a visiting scientistin EPA’s Genetic Toxicology Division, Genetic Bioassay Branch (Research Triangle Park, NC ), a research scientist at the National Institutes of Health, Division of Safety, and a res earch scientist at the National Cancer Institute, Frederick Cancer Research Facility, Environmental C ontrol and Research Program. Dr. Driver also was an adjunct associate professor of medicine (Guest Lecturer) at the School of Public Health & Health Services, George Washington Univers ity Medical Center (1993-1997 and 1997- 2004) and adjunct associate professor of Biology, E nvironmental Sciences and Public Policy at George Mason University, Fairfax, Virginia (1989-19 94). Prior to co-founding risksciences.net, LLC and infoscientific.com, Inc., he was assistant director of the Toxicology Division at Technology Sciences Group, Inc., a subsidiary of Mc Kenna Long & Aldridge.6

Dr. P. Barry Ryan is Professor of Exposure Science and Environmental Chemistry in the Department of Environmental Health, Rollins School of Public Health, Emory University, Georgia, where he is jointly appointed in the Department of Chemistry. Prior to joining the faculty at Emory in 1995, he was on the faculty at Harvard School of Public Health. He received a B.S. degree in Chemistry from the University of M assachusetts, an M.S. in Physical Chemistry from the University of Chicago, and a Ph.D. degree in Computational Chemistry from Wesleyan University, Connecticut. He has been active in the exposure assessment field for more than 25 years and has published in excess of 110 peer-revie wed manuscripts and book chapters and made more than 200 presentations of his work to the scie ntific community. His work has included both cross-sectional and longitudinal studies of communi ty-based exposure for multiple pollutants in multiple media. Dr. Ryan is a principal investigato r on a study assessing exposure to pesticides experienced by individuals in a community in Northe rn Thailand. In addition, he is co-principal investigator and co-investigator on three separate Formative Research projects associated with the National Children’s Study, including a large-sc ale longitudinal study of exposure biomarkers in pregnant African-American women. Finally, he is a principal investigator of a study of the impact of a commuter airport on noise and air pollu tion in the surrounding community. He recently concluded work as principal investigator o f a retrospective study of exposure to perfluorooctanoic acid in a large area surrounding a manufacturing facility using this compound. Dr. Ryan served a 6-year term as a member of the Bo ard of Scientific Counselors for EPA’s Office of Research and Development and a member of EPA’s Science Advisory Board Subcommittee on Exposure and Human Health. Dr. Ryan also completed a 4-year term on the Federal Advisory Committee for the National Childre n’s Study being undertaken by the National

Institutes of Health. He has served on numerous adv isory panels for EPA, most recently as a member of EPA’s Federal Insecticide, Fungicide, Rod enticide Act Science Advisory Panel on Chlorpyrifos Health Effects. Dr. Ryan also has serv ed on several National Academy of Science panels.

Dr. Penelope A. Fenner-Crisp ( proposed chair ) works as a private consultant after retiring as

the executive director of the ILSI Risk Science Ins titute (RSI) in 2004. She received her B.S. degree in Zoology from the University of Wisconsin- Milwaukee and her M.A. and Ph.D. degrees in Pharmacology from the University of Texas Medica l Branch in Galveston, where her research interests were in neuro- and cardiovascular pharmac ology. She completed a Postdoctoral Fellowship in Pharmacology-Morphology from the Phar ma Foundation in the Anatomy Department of the Georgetown University Schools of Medicine and Dentistry, with an emphasis on reproductive endocrinology (1971-1973). Before j oining EPA in 1978, she was an adjunct instructor in the Anatomy Department and a research associate in the Pharmacology Department at Georgetown University, Washington, D.C. During h er more than 22 years at EPA, Dr. FennerCrisp served as senior science advisor to the direc tor and the deputy director of the Office of Pesticide Programs and the director of its Health E ffects Division. She was a special assistant to the assistant administrator for Prevention, Pestici des and Toxic Substances and also served as

director of the Health and Environmental Review Div ision of the Office of Pollution Prevention and Toxics (OPPT). Before that, she was a senior to xicologist in the Health Effects Branch of the Office of Drinking Water. Her responsibilities at E PA included both the hands-on practice, and management oversight, of developing all components of both human health and ecological risk assessments related to drinking water contaminants, industrial chemicals and pesticides. She was a charter member of the Risk Assessment Forum (RAF) , a group of Agency senior scientists who7

are expert in all areas of human, ecological and ex posure assessment, and served as the RAF

chair from 1998 until her retirement from EPA in 20 00. While at EPA, Dr. Fenner-Crisp oversaw the development of the non-regulatory Health Adviso ry for TCE, as well as for other related chlorinated volatile organics; oversaw periodic hum an health risk assessment activities related to TCE, tetrachloroethylene (PCE) and other related ch lorinated organic solvents; served on an expert peer review panel charged with reviewing the draft IRIS document on Trichloroacetic acid, a known and significant TCE metabolite. She h as co-authored several articles and given several presentations that describe the current sta te-of-the-science of the hypothesized mode of action underlying rodent tumors observed following long-term exposure to peroxisome proliferator activating alpha receptor (PPAR

α ) agonists. TCE is a PPAR αagonist that fits this profile.

Dr. Michael Jayjock is a Senior Analyst with The LifeLine Group, a non profit organization dedicated to the development of scientific tools fo r human exposure and risk assessment. He has been with LifeLine for 7 years. He also is a Sole P roprietor of Jayjock Associates, LLC, a forprofit consultancy. Previous to this, he was a seni or research and environmental health and safety fellow and manager for risk assessment at the Rohm and Haas Company, and had been working with that company for 35 years. In his current posi tion, he is responsible for the determination of human health risk from and development of tools for the evaluation of human exposure and risk to chemicals. Dr. Jayjock received both his Ph.D. d egree in Environmental Engineering and his M.S. degree in Environmental Science and Occupation al Health from Drexel University, Pennsylvania. He is a Fellow of the American Industrial Hygiene Association and is certified in the Comprehensive Practice of Industrial Hygiene bythe American Board of Industrial Hygiene. His professional activities include such areas as e xposure modeling research, human exposure/risk assessment to environmental pollutant s and uncertainty analysis. He has published extensively in peer-reviewed publications and serve d from 1998 to 2003 as an Editorial Board

Member for the American Industrial Hygiene Journal. He has made numerous technical presentations, including at the American Industrial Hygiene Conferences and International Society of Exposure Assessment Conferences. His ser vice on advisory committees includes:

EPA’s Board of Scientific Counselors Peer Review Pa nel for the Office of Research and Development, Executive Committee, Human Health Rese arch Strategy Panel ; EPA Office of Pollution Prevention & Toxics - Voluntary Children’ s Chemical Evaluation Program (VCCEP), Peer Consultation Panel on Flame Retardants (2003) and Methyl Ethyl Ketone (2004); EPA’s Science Advisory Board (SAB), Executive Committee, Human Health Research Strategy Panel (November 2002); EPA’s SAB, consultant - IntegratedHuman Exposure Committee (2001- 2003); EPA SAB member - Integrated Human Exposure C ommittee (1998-2001); and National Research Council - National Academy of Sciences, as a Member of the Committee to Review Risk Management in the Department of Energy’s Envir onmental Remediation Program, the Committee on Advances in Assessing Human Exposure t o Airborne Pollutants, and the Committee on Toxicology - Subcommittee on Risk Asse ssment of Flame-Retardant Chemicals.

Dr. David A. Morgott is a board certified toxicologist and industrial hy gienist who has been the Owner and Principal Scientist at Pennsport Consulti ng, LLC, since 2006. Prior to that time, he was a staff scientist at Eastman Kodak Company’s He alth, Safety, and Environment laboratory for more than 20 years. During his tenure at Kodak, he held positions within the Worldwide Toxicology Group, the Scientific and Regulatory Ana lysis Group, the Industrial Hygiene8

Section, and the Biochemical Toxicology Section (19 86 -2007). He earned a B.S. degree in Medical Technology from the State University of New York at Buffalo, and an M.P.H. degree in Industrial Hygiene and Ph.D. degree in Toxicology f rom the University of Michigan. He served a 2-year postdoctoral appointment at Dow Chemical C ompany’s Health Safety and Environment laboratory, where his specialties were the metaboli sm and pharmacokinetics of vapor phase chemicals (1984-1986). Dr. Morgott has served on n umerous technical committees, including the American Industrial Hygiene Association’s Biolo gical Monitoring Committee, the Society of Toxicology Occupational Health Specialty Section, a nd the Chemical Specialties Manufacturers Association’s VOC Reactivity Task Group. He has bee n a contributing author on many chemical reviews, white papers and risk assessments; and has published repeatedly on the metabolism and pharmacokinetics of volatile solvents. Dr. Morgott has written four book chapters for Patty’s Industrial Hygiene and Toxicology, served as a peer reviewer for many toxicology-related journals, and regularly presented and organized pan el sessions at recognized national meetings. His present interests range from exposure and risk modeling to the health effects of primary air pollutants.

Dr. Montserrat Fuentes is Head and Full Professor of Statistics at North Carolina State University (NCSU). Dr. Fuentes received her B.S. de gree in Mathematics and Music (piano) from the University of Valladolid, Spain, and her P h.D. degree in Statistics from the University of Chicago (1999). Dr. Fuentes has authored more th an 70 scientific publications and served as a principal investigator (or co-PI) on more than 20 r esearch grants, with total funding of more than $20 million. She is the principal investigator and director of the Research Network for Statistical Methods for Atmospheric and Oceanic Sciences (STATM OS), a $5 million initiative funded by

the National Science Foundation. Dr. Fuentes was na med an American Statistical Association fellow (2008) for outstanding contributions to rese arch in spatial statistics, for excellence in the development and application of statistical methodol ogy in atmospheric sciences, air pollution and oceanography; and for service to the profession . She is the editor of the Journal of Agricultural, Biological, and Environmental Statist ics (JABES), of the International Biometrics Society. Dr. Fuentes is a member-elect of the Inter national Statistical Institute, and has been a member of the Regional Advisory Board for the Easte rn North American Region of the International Biometric Society. Dr. Fuentes is a m ember of EPA’s Science Advisory Board (SAB) Integrated Human Exposure Committee, and the U.S. representative on the Board of

Directors of the International Environmetrics Socie ty. She was a member of the Biostatistical Methods and Research Design (BMRD) study section of the National Institutes for Health, and she is currently a member of the scientific review committee of Health Canada. She also has worked for the U.S. Department of Justice as an exp ert witness and was a member of a

committee of the National Research Council of the N ational Academies working on the impact of ozone on mortality. She is a senior leader of th e ADVANCE-NSF Developing Diverse Departments program at NCSU. Dr. Fuentes was recen tly awarded the NCSU 2013 Equity of Women award for major contributions to the equity a nd well-being of women at NC State University.